Psychometric properties of the Iranian version of Diabetes Empowerment Scale (IR-DES-28) by Mohammad Mahjouri et al.
Mahjouri et al. Journal of Diabetes & Metabolic Disorders 2012, 11:4
http://www.jdmdonline.com/content/11/4RESEARCH ARTICLE Open AccessPsychometric properties of the Iranian version of
Diabetes Empowerment Scale (IR-DES-28)
Mohammad Yoosef Mahjouri1, Seyed Masoud Arzaghi1,2*, Ramin Heshmat1, Patricia Khashayar1,
Ensieh Nasli Esfahani1 and Bagher Larijani1Abstract
Background: This study was designed to determine the primary psychometric properties of the Iranian version of
the Diabetes Empowerment Scale (IR-DES-28).
Methods: After translating the questionnaire into Persian, re-translating it into English and obtaining the
confirmation of the diabetes specialists regarding the accuracy of the translated questionnaire, 100 patients with
type 2 diabetes selected using a systematic random sampling method completed the Iranian-DES-28. The validity of
IR-DES-28 was evaluated by construct, concurrent and criterion validity, whereas its reliability was assessed by test
re-test, internal consistency and splitting method.
Results: Psychometric analysis confirmed the reliability and validity of the IR-DES-28 in three subscales:
Self-awareness and managing psychological aspects of diabetes (α=0.80), goal achievement ability (α=0.50), the
ability of setting goals (α=0.79). Test-retest reliability, evaluated through Pearson coefficient correlation, was equal to
0.74 (P <0.01). The total score of IR-DES-28 and that of the extracted subscales were correlated with HbA1c levels
(metabolic control) (P <0.01). The findings also supported the concurrent validity of the questionnaire.
Conclusion: The validity and reliability of the Iranian-DES scale is acceptable. Thus, the scale could be an
appropriate instrument in evaluating the empowerment-based education programs.
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Diabetes mellitus is one of the most serious illnesses, now-
adays afflicting many people in Iran and other countries.
Diabetic patients must take a series of daily decisions
regarding nutrition, physical activity, medication, blood
glucose monitoring, and stress management. They must
also interact effectively with the health care system, their
family members, and friends to obtain the support needed
to manage and control their disease [1]. The education
programs in diabetic patients aim to improve the patients’
ability to obtain the self efficacy required to gain control
over daily self-care [2,3]. Anderson et al. described that
self efficacy can be gained through the adaptation of an
empowerment approach, adding that such a technique has
a significant and positive effect on the patient’s metabolic* Correspondence: Dr.arzaghi@gmail.com
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reproduction in any medium, provided the orcontrol and quality of life. They explained that empower-
ment philosophy is based on the assumption that to be
healthy, people need to have the psychosocial skills
required to change their personal behavior, social situa-
tions, and the institutions that influence their lives. These
skills can play an important role in the development and
fulfillment of effective and successful diabetes self care
program [4]. Therefore, empowerment is a strategy and
process through which people obtain greater control over
their decisions and actions related to their health and dia-
betes management [5]. In other words, empowerment in
this area is defined as helping diabetic patients discover
and develop a natural capacity and ability to become re-
sponsible for one’s own life [6]. Previous researches have
indicated that empowering the patients through providing
them with appropriate and sufficient education programs
can increase their knowledge about diabetes and promote
their collaboration with physicians [6-9].al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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powerment education programs. "Diabetes Empowerment
Scale (DES)" is one of the main instruments used in this
regard. The first version of the US-DES was a 37-item
questionnaire with eight subscales, including satisfaction
and dissatisfaction related to living with diabetes; identifi-
cation and achievement of personally meaningful goals;
application of systematic problem-solving process; coping
with emotional aspects of living with diabetes; stress man-
agement; appropriate social support; self-motivating; and
making cost/benefit decisions regarding behavior changes
[4,10]. The assessment of this first version indicated that
only three of these eight subscales has an internal
consistency of greater than 0.80, thus the authors reduced
the questionnaire from 37 to 28 items with three sub-
scales, including managing the psychosocial aspects of
diabetes (α=0.93), assessing dissatisfaction and readiness
to change (α=0.81), and setting and achieving diabetes
goals (α=0.91). The reliability and validity of the recent
version was reported to be acceptable [10]. The US-DES
scale has been translated into other languages such as
Chinese and Swedish, and the psychometric analysis has
supported the validity and reliability of the new versions
similarly [11,12].
In order to evaluate our empowerment education pro-
grams, we likewise need an Iranian version of DES.
Therefore, the aim of this study is to assess the psycho-




This study was conducted in two stages:
1- The preparation of the Persian version of DES-28:
after translating the English version of DES-28 by 3
bilingual translators and thereafter back translating
it, the questionnaire was studied by clinicians and
patients both of them involved in the field of diabetes.
The questionnaire was then modified based on their
opinions.
2- Psychometric evaluations: The last Persian version of
DES-28 was distributed among the participants, who
had given an informed consent, in two stages (at the
beginning of the study and then two months later).
The patients then completed the questionnaires while
they were seated in a comfortable and quiet room.
The DES questions were read to illiterate participants
by the physician and their answers were recorded.
Subjects
The present cross sectional study was conducted in
diabetes clinic of Shariati hospital, Tehran University of
Medical Sciences (TUMS). One hundred patients wereselected from among 4500 patients who had a medical
record in the clinic using a random sampling method.
Patients with type 2 diabetes, who aged more than
18 years and had no serious complication, such as un-
stable coronary artery disease, severe heart failure, stroke
with sequel, end-stage renal disease, severe peripheral
vascular disease and severe psychiatric disorders includ-
ing dementia and schizophrenia that affects the patients’
cognitive ability were enrolled.
The ethic committee of TUMS approved this study
and all patients signed informed consent.
Measurements
We used the 28-item US version of DES with three sub-
scales, including managing the psychosocial aspects of
diabetes, assessing dissatisfaction and readiness to change,
and setting and achieving diabetes goals [10]. A five-point
scale was used to answer the items. The responses ranged
from strongly agree (5 points) to strongly disagree (1 point)
and therefore higher scores indicated better adjustment to
the illness. In addition to DES, the third versions of the
Diabetes Attitude Scale (DAS-3) and the Problem Areas in
Diabetes (PAID) were also filled out by the patients. The
third version of DAS developed in 1998, consists of 33
Likert scale items (5=strongly agree, 1=strongly disagree)
and measures five discrete subscales: need for special train-
ing, seriousness of type 2 diabetes, value of tight control,
psychosocial impact of diabetes, and patient autonomy.
They were also answered using a five-point scale, ranging
from strongly agree to strongly disagree [13]. The PAID
scale is a self-administrated questionnaire that consists of
twenty eight statements identified as common emotional
problems related to living with diabetes. The questionnaire
assesses four domains of diabetes-related quality of life:
emotional distress, treatment barriers, problems related to
food and lack of social support [14,15]. Each item can be
rated using a 5-point Likert scale, ranging from 0 to 4. The
final score is calculated after multiplying the total score,
resulted in through summing the 0–4 responses given for
each of the 20 items, by 1.25. Higher scores indicate greater
emotional distress [16]. The original version of the scale
has proved its validity and reliability [15], also in other stud-
ies indicated that The PAID scale has good psychometric
properties [17-19]. Moreover, a self report questionnaire
was used to record the demographic characteristics (gender
and age) along with data on his/her diabetes treatment,
education, and duration of diabetes) in each patient.
Current HbA1c values were extracted from the patients’
medical records.
Statistical analysis
Data were entered and analyzed using Statistical Package
for the Social Sciences (SPSS-16). The reliability of the
questionnaire was evaluated using internal consistency
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test- retest and splitting methods (spearman-brown coef-
ficient correlation). Also the validity of the questionnaire
was evaluated by construct validity (scores test, varimax
rotation, keiser-meyer-olkin measuring of the samples
and Bartlett’s test of Sphericity), criterion validity (the
correlation between the DES total score and extracted
factors with the duration of diabetes was assessed by
Spearman correlation due to the lack of normal distribu-
tion and the correlation between DES total score and
extracted factors with HbA1c was calculated by Pearson
correlation) and concurrent validity (correlation between
the scores obtained in DES and that of PAID and DAS).
Results
Demographic and clinical data
Totally 100 patients (male=54, female=46) with type 2
diabetes were interviewed. The mean age of the partici-
pants was 52.65 (SD=7.1) years. The average duration of
diabetes in the studied patients was 8.64 (SD=5.80) years
and their mean HbA1c value was equal to 6.86 (SD=0.37).
Twenty one of the participants were illiterate. Twenty one
of the participants were illiterate. Fifty nine subjects used
oral agents, 11 were on insulin and 30 received both oral
agents and insulin (Table 1).
Reliability
The α-coefficient for IR-DES-28’s total score was 0.89
and for its three subscales (calculated by factor analysis)
was 0.80, 0.50, and 0.79, respectively. The results showed

















Insulin and Oral agents 30
* Data for the age, duration of diabetes and HbA1c are mean (SD). (n=100).total test-retest reliability was 0.74 (P <0.01). Moreover
splitting method showed the instrument to be com-
pletely reliable (correlation between the forms=0.73, first




The Keiser-Meyer-Olkin measure of sampling (Kmo=0.77)
and Bartlett’s test of Sphericity (Bts=1197) indicated that
the sample size was suitable for conducting a factor ana-
lysis and the correlation matrix has not occurred by
chance. The result suggested seven factors for this scale.
The method of factor analysis was least factor load. After
an iterative factor processing and item analysis, a three-
factor solution was judged the best (Table 2). The variance
for each factor was reported to be 27.62, 21.65, and 12.65
percent, respectively. The total variance was equal to
61.52% and all the three factors were shown to have eigen-
values higher than 1.0. A list of IR-DES-28 items and its
subscales are displayed in Table 3.
Criterion validity
The existence of any association between HbA1c levels,
as the indicator of metabolic control and duration of
diabetes, and the DES total score and its subscales was
assessed and the result indicated the correlation between
HbA1c levels and IR-DES-28 total score and its subscales
was significant (Table 4).
Concurrent validity
The assessment of correlation between IR-DES-28 and
IR-PAID-20 and IR-DAS-33 scales, indicated a negative
correlation between overall DES-28 and PAID-20 scores
(r=−0.21 and P <0.01) and a positive one between the
overall DES-28 and DAS-33 scores (r=0.42 and P <0.01).
Discussion
The present pilot study aimed to evaluate the valid-
ity and reliability of the Iranian Diabetes Empower-
ment Scale (IR-DES-28). It showed the validity and
reliability of the DES, adding that IR-DES-28 has a
high internal consistency, with overall Cronbach’s α
coefficient of 0.89. Also the test-retest reliability and
splitting method indicated the instrument to be
completely reliable.
The factor analysis resulted in three factors with eigen-
values greater than 1.0. These three factors are as
following:
Factor 1, “Self-awareness and managing psychological
aspects of diabetes,” includes 12 items on self
knowledge, positive and negative coping methods with
diabetes-related stress.
Table 2 Results of psychometrics indicators of factor analysis of IR-DES-28 (n=100)
Factor Eigenvalue Communalities Variance% Cumulative% N. of questions
first 7.73 0.68 27.62 27.62 12
second 2.29 0.53 21.65 49.27 4
third 2.03 0.72 12.25 61.52 12
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items on having knowledge and the ability to
achieve diabetes goals.
Factor 3, “the ability of setting goals,” is about having
knowledge and the ability to determine diabetes goals.
In this study, the factor analysis showed a resem-
blance between the US and the Iranian version of the
questionnaire, as both questionnaires yielded three
subscales [10]. However the number of questions inTable 3 Items of the three subscales of IR-DES-28
Subscale name Items
In general, I believe tha
Self-awareness and . . .know what part(s) of t
managing Psychological . . .know what part(s) of t
aspects of diabetes . . .can tell how I’m feelin
. . .know the positive way
. . .can cope well with dia
. . .know where I can get
. . .can ask for support fo
. . .can support myself in
. . .know what helps me
. . .know enough about d
. . .know enough about m
. . .am able to figure out
Goal achievement ability . . .can choose realistic di
. . .know which of my dia
. . .can reach my diabetes
. . .know which barriers m
The ability of setting goals . . .know what part(s) of t
. . .know what part(s) of t
. . .know the things abou
. . .can come up with goo
. . .am able to turn my di
. . .can think of different w
. . .can try out different w
. . .am able to decide wh
. . .can tell how I’m feelin
. . .know the ways that ha
. . .know the negative wa
. . .can motivate myself toeach subscale differs between the two tools. In
addition, the last C-DES-20 [11] and SW-DES-23 [12]
versions each had five and four subscales, respect-
ively, pointing out a discrepancy between the Iranian
with the Swedish and Chinese versions.
While many of the previous studies have not reported
any significant correlation between metabolic control and
diabetes empowerment [12], the present study showed a
mild negative correlation between these variables. This
finding confirms the criterion validity of the IR-DES-28.t I:
aking care of my diabetes that I am satisfied with.
aking care of my diabetes that I am dissatisfied with.
g about having diabetes.
s I cope with diabetes-related stress.
betes- related stress.
support for having and caring for my diabetes.
r having and caring for my diabetes when I need it.
dealing with my diabetes.
stay motivated to care for my diabetes.
iabetes to make self-care choices that are right for me.
y- self as a person to make diabetes care choices that are right for me.
if it is worth my while to change how I take care of my diabetes.
abetes goals.
betes goals are most important to me.
goals once I make up my mind.
ake reaching my diabetes goals more difficult.
aking care of my diabetes that I am ready to change.
aking care of my diabetes that I am not ready to change.
t myself that either help or prevent me from reaching my diabetes goals.
d ideas to help me reach my goals.
abetes goals into a workable plan.
ays to overcome barriers to my diabetes goals
ays of overcoming barriers to my diabetes goals.
ich way of overcoming barriers to my diabetes goals works best for me.
g about caring for my diabetes.
ving diabetes causes stress in my life.
ys I cope with diabetes-related stress.
care for my diabetes.
Table 4 Correlations between IR-DES-28 and diabetes-related data
Factors duration of diabetes HbA1c
Self-awareness and managing psychological aspect of diabetes −0.05 −0.33a
Goal achievement ability −0.1 −0.33a
Set goals ability −0.08 −0.32a
Total −0.09 −0.36a
Correlations were performed with Pearson’s correlation or Spearman method.
a P <0.01.
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28 and IR-PAID-20 and IR-DAS-33 also confirmed based
on our findings indicates a negative correlation between
overall DES and PAID scores (r=−0.21 and P <0.01) con-
sistent with the study conducted in Iceland [18] and a
positive correlation between overall DES and DAS scores
(r=0.42 and P <0.01). This simply shows that becoming
empowered in diabetes management is associated with ex-
periencing less diabetes-related psychological problems
and adopting a better attitude towards diabetes, all of
which would result in an enhanced diabetes management.
This study demonstrated psychometric properties such
as reliability and validity of the Iranian version of DES
scale was acceptable, these findings are consistent with
previous studies [11,12].
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